We are live on
!
Find out more
KCM
Kingdon Capital Management Portfolio holdings
AUM
$911M
1-Year Est. Return
51.11%
This Fund
S&P 500
This Quarter
Est. Return
+13.65%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.18B
AUM Growth
+$363M
(+20%)
Cap. Flow
+$189M
Cap. Flow
% of AUM
8.65%
Top 10 Holdings %
Top 10 Hldgs %
46.28%
Holding
149
New
49
Increased
29
Reduced
25
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$72.1M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$54M |
| 3 |
International Paper
IP
|
+$45.3M |
| 4 |
APA Corp
APA
|
+$41.6M |
| 5 |
Heron Therapeutics
HRTX
|
+$33.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMC
EMC CORPORATION
EMC
|
+$39.7M |
| 2 |
Charter Communications
CHTR
|
+$37M |
| 3 |
Newell Brands
NWL
|
+$34.9M |
| 4 |
NFX
Newfield Exploration
NFX
|
+$27.8M |
| 5 |
Advance Auto Parts
AAP
|
+$26.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.04% |
| 2 | Consumer Staples | 12.64% |
| 3 | Consumer Discretionary | 8.59% |
| 4 | Energy | 6.82% |
| 5 | Communication Services | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN.PRA
51
DELISTED
Allergan plc
AGN.PRA
| – | – |
0
| – | – |
|
52
CSX Corp
CSX
$92.3B
| $10.2M | 0.47% |
+999,960
| New | +$9.46M |
|
53
Molson Coors Class A
TAP.A
$7.73B
| $9.82M | 0.45% |
+89,473
| New | +$9.11M |
|
54
Blackstone Mortgage Trust
BXMT
$2.46B
| $9.54M | 0.44% |
+324,000
| New | +$9.38M |
|
55
Sinclair Inc
SBGI
$1B
| $9.32M | 0.43% |
322,779
-330,531
| -51% | -$9.58M |
|
|
SGYP
56
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $9.03M | 0.41% |
1,638,410
+35,076
| +2% | +$164K |
|
|
OTIC
57
DELISTED
Otonomy, Inc.
OTIC
| $9.01M | 0.41% |
495,074
+127,487
| +35% | +$2.08M |
|
|
WRK
58
DELISTED
WestRock Company
WRK
| $8.83M | 0.4% |
182,155
-121,176
| -40% | -$5.41M |
|
59
Fate Therapeutics
FATE
$291M
| $8.82M | 0.4% |
2,827,889
+569,969
| +25% | +$1.38M |
|
60
CALL
Mondelez International
MDLZ
$78.8B
| $8.78M | 0.4% |
200,000
-100,000
| -33% | -$4.39M |
|
61
Travere Therapeutics
TVTX
$5.11B
| $8.51M | 0.39% |
+380,075
| New | +$7.23M |
|
62
Gaming and Leisure Properties
GLPI
$12.7B
| $8.13M | 0.37% |
242,925
-44,883
| -16% | -$1.55M |
|
63
CALL
Eli Lilly
LLY
$1,000B
| $8.09M | 0.37% |
100,800
+800
| +0.8% | +$64K |
|
64
Procter & Gamble
PG
$338B
| $8.08M | 0.37% |
+89,985
| New | +$7.82M |
|
|
K
65
CALL
DELISTED
Kellanova
K
| $7.75M | 0.36% |
+106,500
| New | +$8.15M |
|
66
CALL
Vanda Pharmaceuticals
VNDA
$315M
| $7.53M | 0.35% |
452,200
+152,200
| +51% | +$2.05M |
|
67
CALL
Bausch Health
BHC
$2.62B
| $7.38M | 0.34% |
+300,700
| New | +$7.78M |
|
68
Coca-Cola Europacific Partners
CCEP
$47.8B
| $7.13M | 0.33% |
+178,808
| New | +$6.82M |
|
|
TSRO
69
DELISTED
TESARO, Inc.
TSRO
| $6.88M | 0.32% |
+68,608
| New | +$6.41M |
|
|
70
Vanda Pharmaceuticals
VNDA
$315M
| $6.7M | 0.31% |
402,456
-242,112
| -38% | -$3.26M |
|
|
AMAG
71
DELISTED
AMAG Pharmaceuticals
AMAG
| $6.68M | 0.31% |
+272,526
| New | +$6.81M |
|
72
PepsiCo
PEP
$191B
| $6.52M | 0.3% |
+59,920
| New | +$6.46M |
|
73
Monster Beverage
MNST
$91.5B
| $6.41M | 0.29% |
261,954
-17,046
| -6% | -$442K |
|
|
IVTY
74
DELISTED
Invuity, Inc
IVTY
| $6.37M | 0.29% |
464,150
+245,000
| +112% | +$2.91M |
|
|
DVAX
75
DELISTED
Dynavax Technologies
DVAX
| $6M | 0.27% |
571,555
-273,745
| -32% | -$3.93M |
|
Similar funds
GC
ICP
NAM
SAA
GIG
SI
PAMI
BDP
Kingdon Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Kingdon Capital Management held 149 positions worth $2.18B, up 20% from $1.82B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Kingdon Capital Management deployed $189M of net new capital in Q3 2016, opening 49 new positions and adding to 29 existing holdings. Its largest new stake was Amazon: 1,883,140 shares worth $78.8M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 12% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Newell Brands, an estimated $34.9M trimmed.
- Kingdon Capital Management's largest Q3 2016 buy was Amazon: 1,883,140 shares worth $78.8M.
- Kingdon Capital Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2016, an estimated $54M increase.
- Kingdon Capital Management's biggest Q3 2016 reduction was Newell Brands, cutting an estimated $34.9M.
- Kingdon Capital Management fully exited EMC CORPORATION in Q3 2016, selling an estimated $39.7M.
- Kingdon Capital Management's ten largest holdings make up 46% of its $2.18B portfolio in Q3 2016.
- Kingdon Capital Management opened 49 new positions and closed 33 in Q3 2016.
- Kingdon Capital Management's portfolio value rose 20% quarter-over-quarter to $2.18B.
Based on Kingdon Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.